Neurotoxicant exposure during pregnancy is a confounder for assessment of iodine supplementation on neurodevelopment outcome

Neurotoxicology and Teratology

Volumn 51, Issue , 2015, Pages 45-51

  Brucker Davis, Françoise ^a,b   Ganier Chauliac, Fleur ^a   Gal, Jocelyn ^c   Panaïa Ferrari, Patricia ^a   Pacini, Patricia ^d   Fénichel, Patrick ^a,b   Hiéronimus, Sylvie ^a  

^a UNIVERSITY HOSPITAL OF NICE   (France)

^b CENTRE MÉDITERRANÉEN DE MÉDECINE MOLÉCULAIRE C3M   (France)

^c CENTRE ANTOINE LACASSAGNE   (France)

^d Departments of Clinical Research and Innovation and Statistics Epidemiology and Biostatistics Unit Centre Antoine Lacassagne ^*  (France)

Author keywords

Heavy metals; Iodine; Neuro cognitive development; PCB 118; Pregnancy; Thyroid tests; Thyroxine Binding Globulin

Indexed keywords

CADMIUM; IODINE; LEAD; POLYBROMINATED DIPHENYL ETHER; POLYCHLORINATED BIPHENYL; LIOTHYRONINE; THYROTROPIN; THYROXINE; TOPICAL ANTIINFECTIVE AGENT;

ADULT; ARTICLE; BLOOD LEVEL; CHILD; COGNITIVE DEVELOPMENT; COLOSTRUM; CONTROLLED STUDY; DIET SUPPLEMENTATION; EDUCATIONAL STATUS; ENVIRONMENTAL EXPOSURE; EUTHYROIDISM; FEMALE; HUMAN; INTERVENTION STUDY; MAJOR CLINICAL STUDY; MALE; MATERNAL BLOOD; MILK LEVEL; MOTOR DEVELOPMENT; NERVE CELL DIFFERENTIATION; NEUROTOXICITY; PILOT STUDY; PREGNANCY OUTCOME; PRENATAL EXPOSURE; PRIORITY JOURNAL; PROSPECTIVE STUDY; SMOKING HABIT; SOCIAL EVOLUTION; THYROID FUNCTION TEST; UMBILICAL CORD BLOOD; BLOOD; COHORT ANALYSIS; DEVELOPMENTAL DISABILITIES; DIETARY SUPPLEMENT; NEUROPSYCHOLOGICAL TEST; PATHOPHYSIOLOGY; PREGNANCY; RANDOMIZED CONTROLLED TRIAL; STATISTICS; TOXICITY; YOUNG ADULT;

ADULT; ANTI-INFECTIVE AGENTS, LOCAL; COHORT STUDIES; DEVELOPMENTAL DISABILITIES; DIETARY SUPPLEMENTS; FEMALE; HUMANS; IODINE; MALE; NEUROPSYCHOLOGICAL TESTS; PREGNANCY; PRENATAL EXPOSURE DELAYED EFFECTS; STATISTICS AS TOPIC; THYROTROPIN; THYROXINE; TRIIODOTHYRONINE; YOUNG ADULT;

EID: 84940371326     PISSN: 08920362     EISSN: 18729738     Source Type: Journal    
DOI: 10.1016/j.ntt.2015.07.009     Document Type: Article

References (43)

1. Alsherhri B., D'Souza D.G., Lee J.Y., Petratos S., Richardon S.J. The diversity of mechanisms influenced by transthyretin in neurobiology: development, disease and endocrine disruption. J. Neuroendocrinol. 2015, 10.1111/jne.12271.
2. Berbel P., Mestre J.L., Santamaria A., Palazon I., Franco A., Graells M., Gonzalez-Torga A., Morreale de Escobar G. Delayed neurobehavioral development in children born to pregnant women with mild hypothyroxinemia during the first month of gestation: the importance of early iodine supplementation. Thyroid 2009, 19:511-519.
3. Berg V., Lyche J.L., Gutleb A.C., Lie E., Skaare J.U., Aleksandersen M., Ropstad E. Distribution of PCB 118 and PCB 153 and hydroxylated PCB metabolites (OH-CBs) in maternal, fetal and lamb tissues of sheep exposed during gestation and lactation. Chemosphere 2010, 80:1144-1150.
4. Boucher O., Muckle G., Bastien C.H. Prenatal exposure to PCBs: a neuropsychological analysis. Environ. Health Perspect. 2009, 117:7-16.
5. Boucher O., Bastien C.H., Saint-Amour D., Dewailly E., Ayotte P., Jacobson J.L., Jacobson S.W., Muckle G. Prenatal exposure to methylmercury and PCBs affects distinct stages of information processing: an event-related potential study with Inuit children. Neurotoxicology 2010, 31:373-384.
6. Brucker-Davis F. Effects on environmental synthetic chemicals on thyroid function. Thyroid 1998, 8:827-856.
7. Brucker-Davis F., Panaia-Ferrari P., Gal J., Fenichel P., Hieronimus S. Iodine supplementation throughout pregnancy does not prevent the drop in FT4 in the second and third trimesters in women with normal initial thyroid function. Eur. Thyroid J. 2013, 2:187-194.
8. Craig W.Y., Allan W.C., Kloza E.M., Pulkkinen A.J., Waisbren S., Spratt D.I., Palomaki G.E., Neveux L.M., Haddow J.E. Mid-gestational maternal free thyroxine concentration and offspring neurocognitive development at age two years. J. Clin. Endocrinol. Metab. 2012, 97:E22-E28.
9. Dallaire R., Dewailly E., Pereg D., Dery S., Ayotte P. Thyroid function and plasma concentrations of polyhalogenated compounds in Inuit adults. Environ. Health Perspect. 2009, 117:1380-1386.
10. Doi H., Nishitani T., Nagai T., Kakeyama M., Maeda T., Shinohara K. Prenatal exposure to a PCB congener influences fixation duration on biological motion at 4-months-old: a preliminary study. PLoS ONE 2013, 8:e59196. 10.1371/journal.pone.0059196.
11. Farina M., Rocha J.B.T., Aschner M. Mechanisms of methylmercury-induced neurotoxicity: evidence from experimental studies. Life Sci. 2011, 89:555-563.
12. Fischer L.J., Seegal R.F., Ganey P.E., Pessah I.N., Kodavanti P.R.S. Symposium overview: toxicity of non-coplanar PCBs. Toxicol. Sci. 1998, 41:49-61.
13. Fritsche E., Cline J.E., Nguyen N.-H., Scanlan T.S., Abel J. PCBs disturb differentiation of normal human neural progenitor cells: clue of involvement of thyroid hormone receptors. Environ. Health Perspect. 2005, 113:871-876.
14. Giera S., Bansal R., Ortiz-Toro T.M., Taub D.G., Zoeller R.T. Individual PCB congeners produce tissue- and gene-specific effects on thyroid hormone signalling during development. Endocrinology 2011, 52:2909-2919.
15. Gilbert M.E., Rovet J., Chen Z., Koibuchi N. Developmental thyroid hormone disruption: prevalence, environmental contaminants and neurodevelopmental consequences. Neurotoxicology 2012, 33:842-852.
16. Gilbert M.E., Hedge J.M., Valentin-Blasini L., Blount B.C., Kannan K., Tietge J., Zoeller R.T., Crofton K.M., Jarrett J.M., Fisher J.W. An animal model of marginal iodine deficiency during development: the thyroid axis and neurodevelopmental outcome. Toxicol. Sci. 2013, 132:177-195.
17. Goldey E.S., Taylor D.H. Developmental toxicity following premating maternal exposure to hexachlorobenzene in rats. Neurotoxicol. Teratol. 1992, 14:15-21.
18. Hansen L.G. Stepping backward to improve assessment of PCB congener toxicities. Environ. Health Perspect. 1998, 106(Suppl. 1):171-189.
19. Henrichs J., Bongers-Schokking J.J., Schenk J.J., Ghassabian A., Schmidt H.G., Visser T.J., Hooijkaas H., de Muinck Keizer-Schrama S.M.P.F., Hofman A., Jaddoe V.V.W., Visser W., Steegers E.A.P., Verhulst F.C., Rijke Y.B., Tiemeier H. Maternal thyroid function in early pregnancy and cognitive functioning in early childhood: the generation R study. J. Clin. Endocrinol. Metab. 2010, 95:4227-4234.
20. Herbstman J.B., Sjödin A., Kurzon M., Lederman S.A., Jones R.S., Rauh V., Needham L., Tang D., Niedzwiecki M., Wang R.Y., Perera F. Prenatal exposure to PBDEs and neurodevelopment. Environ. Health Perspect. 2010, 118:712-719.
21. Hiéronimus S., Ferrari P., Gal J., Berthier F., Azoulay S., Bongain A., Fénichel P., Brucker-Davis F. Relative impact of iodine supplementation and maternal smoking on cord blood thyroglobulin in pregnant women with normal thyroid function. Eur. Thyroid J. 2012, 1:264-273.
22. Hisada A., Shimodaira K., Okai T., Watanabe K., Takemori H., Takasuga T., Noda Y., Shirakawa M., Kato N., Yoshinaga J. Serum levels of hydroxylated PCBs, PCBs and thyroid hormone measures of Japanese pregnant women. Environ. Health Prev. Med. 2013, 18:205-214.
23. Kim Y., Ha E.-H., Park H., Ha M., Kim Y., Hong Y.-C., Kim E.-J., Kim B.-N. Prenatal lead and cadmium co-exposure and infant neuro-development at 6months of age: the Mothers and Children's Environmental Health (MOCEH) study. Neurotoxicology 2012, 35:15-22.
24. Ma Z.F., Skeaff S.A. Thyroglobulin as a biomarker of iodine deficiency: a review. Thyroid 2014, 24:1195-1209.
25. Mason L.H., Harp J.P., Han D.Y. Pb neurotoxicity: neuropsychological effects of lead toxicity. Biomed. Res. Int. 2014, 10.1155/2014/840547.
26. Oken E., Braverman L.E., Platek D., Mitchell M.L., Lee S.L., Pearce E.N. Neonatal thyroxine, maternal thyroid function, and child cognition. J. Clin. Endocrinol. Metab. 2009, 94:497-503.
27. Preau L., Fini J.B., Morvan-Dubois G., Demeneix B. Thyroid hormone signaling during early neurogenesis and its significance as a vulnerable window of endocrine disruption. Biochim. Biophys. Acta 2014, 10.1016/jbbagrm.2014.06.015.
28. Rebagliato M., Murcia M., Alvarez-Pedrerol M., Espada M., Fernandez-Somoano A., Lertxundi N., Navarrete-Munoz E.M., Forns J., Aranbarri A., Llop S., Julvez J., Tardon A., Ballester F. Iodine supplementation during pregnancy and infant neuropsychological development INMA mother and child cohort study. Am. J. Epidemiol. 2013, 177:944-953.
29. Ribas-Fito N., Torrent M., Carrizo D., Munoz-Ortiz L., Julvez J., Grimalt J.O., Sunyer J. In utero exposure to background concentrations of DDT and cognitive functioning among preschoolers. Am. J. Epidemiol. 2006, 164:955-962.
30. Ribas-Fito N., Julvez J., Torrent M., Grimalt J.O., Sunyer J. Beneficial effects of breastfeeding on cognition regardless of DDT concentrations at birth. Am. J. Epidemiol. 2007, 166:1198-1202.
31. Richard K., Li H., Landers K.A., Patel J., Mortimer R.H. Placental transport of thyroid hormone and iodide. Recent Advances in Research on the Human Placenta 2012, 309-334. (chapter 15). J. Zheng (Ed.).
32. Rodier P.M. Environmental causes of central nervous system maldevelopment. Pediatrics 2004, 113(Suppl. 4):1076-1083.
33. Rovet J. The role of thyroid hormones for brain development and cognitive function. Paediatr. Thyroidol Endocr. Dev. 2014, 26:26-43.
34. Santiago P., Velasco I., Muela J.A., Sanchez B., Martinez J., Rodriguez A., Berrio M., Gutierrez-Repiso C., Carreira M., Moreno A., Garcia-Fuentes E., Soriguer F. Infant neurocognitive development is independent of the use of iodised salt or iodine supplements given during pregnancy. Br. J. Nutr. 2013, 110:831-839.
35. Stagnaro-Green A., Pearce E.N. Iodine and pregnancy: a call to action. Lancet 2013, 382:292-293.
36. Taylor P.N., Okosieme O.E., Dayan C.M., Lazarus J.H. Impact of iodine supplementation in mild to moderate iodine deficiency: systematic review and meta-analysis. Eur. J. Endocrinol. 2014, 170:R1-R15.
37. Trumpff C., De Schepper J., Tafforeau J., Van Oyen H., Vanderfaeillie J., Vandevijvere S. Mild iodine deficiency in pregnancy in Europe and its consequences for cognitive and psychomotor development of children: a review. J. Trace Elem. Med. Biol. 2013, 27:174-183.
38. Velasco I., Carreira M., Santiago P., Muela J.A., Garcia-Fuentes E., Sanchez-Munoz B., Garriga M.J., Gonzalez-Fernandez M.C., Rodriguez A., Caballero F.F., Machado A., Gonzalez-Romero S., Anarte M.T., Soriguer F. Effect of iodine prophylaxis during pregnancy on neurocognitive development of children during the first two years of life. J. Clin. Endocrinol. Metab. 2009, 94:3234-3241.
39. Wang B., Du Y. Cadmium and its neurotoxic effects. Oxidative Med. Cell. Longev. 2013, 10.1155/2013/898034.
40. Williams F.L.R., Watson J., Ogston S.A., Visser T.J., Hume R., Willatts P. Maternal and umbilical cord levels of T4, FT4, TSH, TPOAb, and TgAb in term infants and neurodevelopmental outcome at 5.5 years. J. Clin. Endocrinol. Metab. 2013, 98:829-838.
41. Wirth E.K., Schweizer U., Köhrle J. Transport of thyroid hormone in brain. Mini review article. Front. Endocrinol. 2014, 5:98. 10.3389/fendo.2014.00098.
42. Zimmermann M.B. Iodine deficiency. Endocr. Rev. 2009, 30:376-408.
43. Zoeller R.T., Rovet J. Timing of thyroid hormone action in the developing brain: clinical observations and experimental findings. J. Neuroendocrinol. 2004, 16:809-818.